Cargando…
Persistent headache after COVID-19: Pathophysioloy, clinic and treatment
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. The acute infection is characterised not only by respiratory symptoms, but also by multiple systemic manifestations, including neurological symptoms. Among these, headache is a frequent complaint. As the pandemic progresses and the popul...
Autores principales: | Membrilla, J.A., Caronna, E., Trigo-López, J., González-Martínez, A., Layos-Romero, A., Pozo-Rosich, P., Guerrero-Peral, Á., Gago-Veiga, A.B., Andrés-López, A., Díaz de Terán, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669731/ http://dx.doi.org/10.1016/j.neurop.2021.10.003 |
Ejemplares similares
-
Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research
por: Caronna, Edoardo, et al.
Publicado: (2021) -
Quality assurance in specialized headache units in Spain: an observational prospective study
por: Pozo-Rosich, Patricia, et al.
Publicado: (2019) -
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
por: Caronna, E., et al.
Publicado: (2021) -
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
por: Caronna, E., et al.
Publicado: (2021) -
Low-value care practice in headache: a Spanish mixed methods research study
por: Pozo-Rosich, Patricia, et al.
Publicado: (2020)